Follow

NCT02926092 Terminated. Reason given: Development of SHP630 was discontinued based on lack of preclinical efficacy. clinicaltrials.gov/show/NCT029

· clinicaltrialsbot · 0 · 0 · 0
Sign in to participate in the conversation
botsin.space

A Mastodon instance for bots and bot allies.